| 人胰岛素类似物(Insulin Aspart)持续皮下注射治疗2型糖尿病 |
| |
| 引用本文： | 郭瑞金,薛元明,施珏,蔡玮.人胰岛素类似物(Insulin Aspart)持续皮下注射治疗2型糖尿病[J].中华内分泌代谢杂志,2005,21(3):278-279. |
| |
| 作者姓名： | 郭瑞金 薛元明 施珏 蔡玮 |
| |
| 作者单位： | 650032,昆明,云南省第一人民医院内分泌代谢科 |
| |
| 摘 要： | 观察持续皮下胰岛素注射治疗(CSII)2型糖尿病。在给予短效胰岛素(Novolin R,42例)和给予人胰岛素类似物Insulin Aspart(46例)的5 d治疗中,2组在血糖控制上差异无统计学意义,InsulinAspart用量明显少于Novolin R。在CSII治疗2型糖尿病中,Insulin Aspart与Novolin R均安全有效,InsulinAspart用量少,优于Novolin R。
|
| 关 键 词： | 糖尿病 2型 胰岛素输注系统 Aspart胰岛素 |
| 修稿时间： | 2004年1月27日 |
Continuous subcutaneous injection of human insulin analog (Insulin Aspart) treats type 2 diabetes mellitus |
| |
| GUO Rui-jin,XUE Yuan-ming,SHI Jue,CAI Wei.Continuous subcutaneous injection of human insulin analog (Insulin Aspart) treats type 2 diabetes mellitus[J].Chinese Journal of Endocrinology and Metabolism,2005,21(3):278-279. |
| |
| Authors: | GUO Rui-jin XUE Yuan-ming SHI Jue CAI Wei |
| |
| Abstract: | The effect of continuous subcutaneous insulin injection (CSII) treatment in type 2 diabetic patients was observed. Forty-six cases and 42 cases were treated with Insulin Aspart (human insulin analogue) and Novolin R (human insulin) for 5 days, respectively. There was no difference in controlling blood glucose between two groups. Both Novolin R and Insulin Aspart during CSII treatment in type 2 diabetes were safe and efficient. The doses of Insulin Aspart were significantly lower than those of Novolin R, thus, it seems that the former was more efficient than the latter. |
| |
| Keywords: | Diabetes mellitus type 2 Insulin infusion systems Insulin Aspart |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
